Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 33, Issue 5, Pages 500-510
Publisher
Elsevier BV
Online
2022-03-17
DOI
10.1016/j.annonc.2022.02.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
- (2021) Thomas Powles et al. NATURE
- Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
- (2021) David M. Kurtz et al. NATURE BIOTECHNOLOGY
- Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease
- (2021) Everett J. Moding et al. Cancer Discovery
- Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer
- (2020) Heather A. Parsons et al. CLINICAL CANCER RESEARCH
- Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
- (2020) Asaf Zviran et al. NATURE MEDICINE
- ctDNA monitoring using patient-specific sequencing and integration of variant reads
- (2020) Jonathan C. M. Wan et al. Science Translational Medicine
- Clonal haematopoiesis: a source of biological noise in cell-free DNA analyses
- (2019) C Abbosh et al. ANNALS OF ONCOLOGY
- Perioperative dynamic changes in circulating tumor DNA in lung cancer patients (DYNAMIC)
- (2019) Kezhong Chen et al. CLINICAL CANCER RESEARCH
- Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
- (2019) Bradon R. McDonald et al. Science Translational Medicine
- Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer
- (2019) Tej D. Azad et al. GASTROENTEROLOGY
- Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
- (2018) Davina Gale et al. PLoS One
- Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling
- (2018) Vincent Plagnol et al. PLoS One
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Utilizing circulating tumour DNA in radiation oncology
- (2017) Ariana Rostami et al. RADIOTHERAPY AND ONCOLOGY
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- (2017) Aadel A. Chaudhuri et al. Cancer Discovery
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
- (2016) Zhongwu Lai et al. NUCLEIC ACIDS RESEARCH
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
- (2016) Christine A. Parkinson et al. PLOS MEDICINE
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
- (2015) Isaac Garcia-Murillas et al. Science Translational Medicine
- Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
- (2015) Muhammed Murtaza et al. Nature Communications
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- Detection and quantification of rare mutations with massively parallel sequencing
- (2011) I. Kinde et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started